283 related articles for article (PubMed ID: 30078657)
1. Cost-effectiveness estimates of vaccination against rotavirus in Piedmont, Italy.
Gualano MR; Thomas R; Gili R; Scaioli G; Voglino G; Zotti C
J Infect Public Health; 2018; 11(6):867-872. PubMed ID: 30078657
[TBL] [Abstract][Full Text] [Related]
2. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of childhood rotavirus vaccination in Germany.
Aidelsburger P; Grabein K; Böhm K; Dietl M; Wasem J; Koch J; Ultsch B; Weidemann F; Wichmann O
Vaccine; 2014 Apr; 32(17):1964-74. PubMed ID: 24561052
[TBL] [Abstract][Full Text] [Related]
4. An economic analysis of rotavirus vaccination in Italy.
Giammanco MD; Coniglio MA; Pignato S; Giammanco G
Vaccine; 2009 Jun; 27(29):3904-11. PubMed ID: 19446934
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France.
Standaert B; Parez N; Tehard B; Colin X; Detournay B
Appl Health Econ Health Policy; 2008; 6(4):199-216. PubMed ID: 19382820
[TBL] [Abstract][Full Text] [Related]
6. Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination.
Shim E; Galvani AP
Vaccine; 2009 Jun; 27(30):4025-30. PubMed ID: 19389452
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.
Atkins KE; Shim E; Carroll S; Quilici S; Galvani AP
Vaccine; 2012 Nov; 30(48):6766-76. PubMed ID: 23000223
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland.
Tilson L; Jit M; Schmitz S; Walsh C; Garvey P; McKeown P; Barry M
Vaccine; 2011 Oct; 29(43):7463-73. PubMed ID: 21821085
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.
Javanbakht M; Moradi-Lakeh M; Yaghoubi M; Esteghamati A; Mansour Ghanaie R; Mahmoudi S; Shamshiri AR; Zahraei SM; Baxter L; Shakerian S; Chaudhri I; Fleming JA; Munier A; Baradaran HR
Vaccine; 2015 May; 33 Suppl 1():A192-200. PubMed ID: 25919160
[TBL] [Abstract][Full Text] [Related]
11. Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination.
Bruijning-Verhagen P; Mangen MJ; Felderhof M; Hartwig NG; van Houten M; Winkel L; de Waal WJ; Bonten MJ
BMC Med; 2013 Apr; 11():112. PubMed ID: 23622110
[TBL] [Abstract][Full Text] [Related]
12. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.
Bar-Zeev N; Tate JE; Pecenka C; Chikafa J; Mvula H; Wachepa R; Mwansambo C; Mhango T; Chirwa G; Crampin AC; Parashar UD; Costello A; Heyderman RS; French N; Atherly D; Cunliffe NA;
Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S220-8. PubMed ID: 27059360
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
Patel HD; Roberts ET; Constenla DO
Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study.
Lee H; Park SY; Clark A; Debellut F; Pecenka C; Kim DS; Kim HM; Kim JH; Cho H; Kim AY; Lee M; Jung SY; Seong BL; Kang HY
Vaccine; 2019 Aug; 37(35):4987-4995. PubMed ID: 31326252
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: a model-based evaluation.
Fisman DN; Chan CH; Lowcock E; Naus M; Lee V
Vaccine; 2012 Dec; 30(52):7601-7. PubMed ID: 23107595
[TBL] [Abstract][Full Text] [Related]
17. Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq.
Weycker D; Sofrygin O; Kemner JE; Pelton SI; Oster G
Vaccine; 2009 Aug; 27(36):4930-7. PubMed ID: 19555715
[TBL] [Abstract][Full Text] [Related]
18. The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands.
Goossens LM; Standaert B; Hartwig N; Hövels AM; Al MJ
Vaccine; 2008 Feb; 26(8):1118-27. PubMed ID: 18215445
[TBL] [Abstract][Full Text] [Related]
19. Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia.
Reyes JF; Wood JG; Beutels P; Macartney K; McIntyre P; Menzies R; Mealing N; Newall AT
Vaccine; 2017 Jan; 35(2):345-352. PubMed ID: 27916411
[TBL] [Abstract][Full Text] [Related]
20. Budget impact and cost-utility analysis of universal infant rotavirus vaccination in Spain.
Imaz I; Rubio B; Cornejo AM; González-Enríquez J
Prev Med; 2014 Apr; 61():116-21. PubMed ID: 24360847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
